Report: Life sciences M&A and the rise of personalized medicine
from HIT Consultant
As the life sciences M&A reaches new heights, there seems to be no end in sight for life sciences companies’ hunger for acquisitions. Ninety-four percent of life sciences companies are planning to make an acquisition in the next year, with 91 percent of U.S. respondents expecting these to be cross-border transactions, according to a global study of 100 senior executives at life sciences companies by global law firm Reed Smith, commissioned by Mergermarket.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063